Abeona Therapeutics Inc.

NASDAQ: ABEO · Real-Time Price · USD
7.12
-0.11 (-1.52%)
At close: Aug 15, 2025, 3:59 PM
7.13
0.14%
After-hours: Aug 15, 2025, 06:57 PM EDT

Abeona Therapeutics Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Net Income
-44.19M -63.73M -71.03M -52.6M -76.66M -54.19M -38.72M -36.37M -28.01M -39.7M -85.25M -82.81M -89.72M -84.94M -54.08M -54.27M -52.08M
Depreciation & Amortization
3M 2.91M 2.85M 2.88M 3.03M 3.2M 3.49M 3.82M 4.35M 4.58M 4.76M 4.76M 4.49M 4.46M 4.37M 4.39M 4.38M
Stock-Based Compensation
5.08M 6.65M 6.21M 5.96M 5.56M 4.77M 4.09M 3.16M 2.96M 3.05M 4.22M 6.12M 7.83M 8.92M 10.21M 9.08M 8.42M
Other Working Capital
-4.67M -4.97M -2.33M -3.34M -5.21M -3.15M -2.64M -231K 51K -402K -15.93M -16.13M -12.85M -10.8M 4.67M -1.91M -3.18M
Other Non-Cash Items
-18.79M 2.55M 13.61M -1.77M 22.93M 3.08M -12.53M -12.71M -14.1M -5.54M 5.1M -1.78M -395K -6.55M -5.97M 699K 511K
Deferred Income Tax
n/a n/a -793K 313K 7.92M 7.92M 8.72M 7.61M n/a n/a 32.47M 30.71M 30.71M 30.71M -1.76M n/a n/a
Change in Working Capital
-4.99M -4.38M 468K 3.01M -2.59M -1.79M -6.81M -8.34M -6.75M -5.89M -21.06M -20.29M -18.68M -18.26M 10.22M 2.72M 3.4M
Operating Cash Flow
-59.88M -56.02M -48.69M -42.2M -39.8M -37.01M -41.77M -42.81M -41.54M -43.48M -59.75M -63.29M -65.77M -65.67M -37.02M -37.39M -35.37M
Capital Expenditures
-3.12M -2.45M -1.88M -1.52M -838K -331K -319K -277K -1.73M -1.62M -4.84M -5.24M -3.81M -4.15M -936K -805K -1.3M
Cash Acquisitions
n/a n/a 17K 61K 93K -2.34M -2.21M -2.15M -695K 1.73M -1.66M -1.36M -2.85M -2.4M 2.18M 2.05M 2.6M
Purchase of Investments
-176.31M -157.01M -149.94M -127.37M -73.02M -51.64M -82.56M -57.93M -78.69M -78.21M -48.87M -54.6M -27.65M -35.33M -61.57M -62.57M -110.24M
Sales Maturities Of Investments
152.21M 120.2M 105.2M 69.68M 63.83M 51.97M 45.94M 41.56M 54.37M 52.64M 59.95M 76.15M 74.06M 90.38M 111.19M 105.05M 113.08M
Other Investing Acitivies
18K 18K 18K -18K 111K 2.54M 2.54M 2.58M 3.92M 1.49M 4.74M 19.5M 18.01M 17.57M 12.98M -2.05M -2.6M
Investing Cash Flow
-27.21M -39.24M -46.59M -59.16M -9.82M 208K -36.61M -16.22M -22.83M -23.96M 9.32M 34.44M 57.76M 66.06M 63.84M 41.67M 1.53M
Debt Repayment
-20M n/a 20M 20M 20M n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Common Stock Repurchased
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Financial Acitivies
19.46M 18.51M -1.61M -1.31M -1.3M -332K -18K -14K -9K -5K -1.45M -1.31M -1.29M -623K 831K 691K 667K
Financial Cash Flow
85.47M 104.14M 106.29M 129.57M 62.5M 37.06M 72.36M 53.57M 43.17M 43.17M 16.74M 12.72M 18.98M 24.86M 8.53M 8.36M 7.81M
Net Cash Flow
-1.62M 8.88M 11.01M 28.2M 12.88M 256K -6.02M -5.46M -15.31M -18.38M -27.79M -10.24M 10.98M 25.26M 35.36M 12.64M -26.02M
Free Cash Flow
-63M -58.46M -50.57M -43.72M -40.64M -37.34M -42.09M -43.09M -43.27M -45.1M -64.59M -68.53M -69.58M -69.82M -37.95M -38.19M -36.67M